Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07378839 · ClinicalTrials.gov registry record · NA

Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting

A NA study of Nausea and Pregnancy Emesis, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07378839 is a NA study of Nausea and Pregnancy Emesis that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 100 participants, below the 238-participant average among 17 other Nausea trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07378839, a NA study of Nausea and Pregnancy Emesis, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This is a prospective, two-arm, non-blinded randomized controlled study designed to evaluate the effects of a one-week alternate nostril breathing (ANB) intervention on nausea and vomiting severity in pregnant individuals during their first trimester.

Conditions Studied

Interventions

  • BEHAVIORAL Alternate Nostril Breathing

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-02-10
Est. Completion 2027-03-31
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT07378839

The ClinicalTrials.gov registry entry for NCT07378839 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 238-participant average among 17 other Nausea trials with a reported enrollment target (58% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Nausea appearing as the primary indexed condition, and to 1 intervention - of which Alternate Nostril Breathing is the first listed.

NCT07378839 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07378839 about?

NCT07378839 is a clinical study titled "Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting". This is a prospective, two-arm, non-blinded randomized controlled study designed to evaluate the effects of a one-week alternate nostril breathing (ANB) intervention on nausea and vomiting severity in pregnant individuals during their first trimester.

What is the current status of trial NCT07378839?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-02-10. Estimated completion is 2027-03-31.

What conditions does trial NCT07378839 study?

This clinical trial studies the following conditions: Nausea, Pregnancy Emesis.

What interventions are being tested in trial NCT07378839?

The interventions under investigation include: Alternate Nostril Breathing (BEHAVIORAL).

Who is sponsoring clinical trial NCT07378839?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07378839 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nausea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.